These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 19075682)
41. [Use of monoclonal antibodies in therapeutics. Conclusion]. Monier R C R Biol; 2006 Apr; 329(4):263-4. PubMed ID: 16644497 [No Abstract] [Full Text] [Related]
42. Monoclonal antibody therapeutics: history and future. Buss NA; Henderson SJ; McFarlane M; Shenton JM; de Haan L Curr Opin Pharmacol; 2012 Oct; 12(5):615-22. PubMed ID: 22920732 [TBL] [Abstract][Full Text] [Related]
48. New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer. Thill M Expert Rev Anticancer Ther; 2015 Mar; 15(3):331-8. PubMed ID: 25539719 [TBL] [Abstract][Full Text] [Related]
49. Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China. Zhang MY; Li J; Hu H; Wang YT Health Res Policy Syst; 2015 Nov; 13():64. PubMed ID: 26537659 [TBL] [Abstract][Full Text] [Related]
50. Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies. Taylor RP; Lindorfer MA Semin Immunol; 2016 Jun; 28(3):309-16. PubMed ID: 27009480 [TBL] [Abstract][Full Text] [Related]
52. The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin. Marks L MAbs; 2012; 4(3):403-12. PubMed ID: 22531443 [TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases. An Z Protein Cell; 2010 Apr; 1(4):319-330. PubMed ID: 21203944 [TBL] [Abstract][Full Text] [Related]
57. Trends in risks associated with new drug development: success rates for investigational drugs. DiMasi JA; Feldman L; Seckler A; Wilson A Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567 [TBL] [Abstract][Full Text] [Related]
58. Antibodies to watch in 2014: mid-year update. Reichert JM MAbs; 2014; 6(4):799-802. PubMed ID: 24846335 [TBL] [Abstract][Full Text] [Related]
59. [Monoclonals antibodies: a recent and major therapeutic advance]. Paintaud G; Lejarre F; Ternant D; Goupille P; Watier H Therapie; 2009; 64(1):1-7. PubMed ID: 19463247 [TBL] [Abstract][Full Text] [Related]
60. Preclinical development of monoclonal antibodies: considerations for the use of non-human primates. Chapman K; Pullen N; Coney L; Dempster M; Andrews L; Bajramovic J; Baldrick P; Buckley L; Jacobs A; Hale G; Green C; Ragan I; Robinson V MAbs; 2009; 1(5):505-16. PubMed ID: 20065651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]